Bachem Holding AG Soars with Strong Financial Performance in H1 2025
Bachem Holding AG, a Swiss leader in peptide and oligonucleotide development, reported a 30% increase in sales and 64% jump in EBITDA in the first half of 2025, driven by strong market demand and strategic growth.
2 minutes to read